Is ISRG stock a Buy, Sell, or Hold?

Based on our analysis, ISRG is currently a HOLD with moderate confidence. 📊 HOLD: ISRG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of ISRG stock?

Our analysis estimates the fair value range for ISRG to be between $439.39 and $471.01. The current price is $421.12.

What is the analyst price target for ISRG?

The average Wall Street analyst price target for ISRG is $577.01. This implies a potential upside of 37.0% from current levels.

ISRG Stock Analysis: Buy, Sell, or Hold?

ISRG - Intuitive Surgical Inc.

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

$421.12

-6.94 (-1.62%) ▼

5d: -6.43%

30d: -8.07%

90d: -13.32%

HOLD

MODERATE Confidence

Protect Your ISRG Gains

Analysis Updated: May 15, 2026 12:00 AM ET

Earnings: Apr 21, 2026 0d

Smart Money Accumulation

ISRG is down 4.4% this week, but smart money is accumulating calls. Top strike: $500 2026-06-18 with 795 OI. Call ratio: 61% View Scanner →

Strength: 7.5/10

Get Alerted When ISRG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: ISRG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 13.2%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$444.22

Based on 8.6% avg growth

INTRINSIC VALUE TODAY

$275.83

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ISRG is currently trading at $421.12, which is considered oversold relative to its 30-day fair value range of $439.39 to $471.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 35.7) compared to its historical average (46.5). Remarkably, the market is currently pricing in an annual earnings decline of 8.4% over the next few years. This pessimistic expectation contrasts with the company's recent 18.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $417.74. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: ISRG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $577.01 (+37.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $439.39 - $471.01

Company Quality Score 58/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding ISRG? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 37.0% below Wall St target ($577.01)
CAUTION: 5-day price weakness (-6.4%) - monitor closely

Trading Range Analysis

30-Day Trading Range $439.39 - $471.01

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $417.74

Resistance Level $462.40

Current Trend Strong Downtrend

Technical data as of May 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) 35.72

Wall Street Target $577.01 (+37.0%)

Revenue Growth (YoY) 23.0%

Earnings Growth (YoY) 18.8%

Profit Margin 28.1%

Valuation Discount vs History -8.4% cheaper

PE vs Historical 35.7 vs 46.5 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -8.4% (market-implied from PE analysis)

1-Year Target $385.75 (-8%)

2-Year Target $353.34 (-16%)

3-Year Target $323.66 (-23%)

3-Yr Target (if PE normalizes) (PE: 36→47) $421.33 (+0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 35.7, Growth: 13.2%) $611.57 (+45%)

Base: (SPY PE: 22.1, Growth: 13.2%) $377.85 (-10%)

Bear: (PE: 18.8, Growth: 13.2%) $321.18 (-24%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (52x PE), but valuation improves significantly next year (36x PE) as earnings recover.

Trailing PE: 52.08 | Current EPS (TTM): $8.22

Bull Case $675.32 (+60%)

Analyst growth 43.4%, PE expands to 57.3

Base Case $613.93 (+46%)

Market implied 43.4%, PE stable at 52.1

Bear Case $291.08 (-31%)

Severe decline -20.0%, PE contracts to 44.3

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 35.7 to 46.5

Stabilization Target: $548.20 (+30.2%)

PE Expansion Potential: +30.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: May 18, 2026 2:23 AM ET
Data refreshes hourly during market hours. Next update: 3:23 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ISRG showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Ro Khanna BUY 2026-03-23

Myriam Curet SELL 105 shares 2026-03-10

Mark Brosius SELL 645 shares 2026-03-09

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ISRG.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ALC Alcon AG	STRONG BUY 27 analysts	$88	53 HOLD
RMD ResMed Inc	BUY 19 analysts	$271	59 HOLD
RGEN Repligen Corporation	STRONG BUY 19 analysts	$179	49 HOLD
COO The Cooper Companies, Inc	BUY 19 analysts	$91	64 BUY
WST West Pharmaceutical Serv…	STRONG BUY 13 analysts	$350	58 HOLD

RGEN Repligen Corporat…

49 HOLD

COO The Cooper Compan…

64 BUY

WST West Pharmaceutic…

58 HOLD

Advanced ISRG Option Strategies

Professional options setups generated by AI based on today's ISRG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ISRG

ISRG Technical Chart ISRG Price Prediction ISRG Earnings Date ISRG Investment Advisor ISRG Fair Price Analyzer ISRG Options Advisor ISRG Options Chain ISRG Options Analysis ISRG Competitors

Compare ISRG with Peers

ISRG vs VRTX
Which one to buy?

ISRG vs NOW
Which one to buy?

ISRG vs ILMN
Which one to buy?

ISRG vs CRM
Which one to buy?

ISRG vs LRCX
Which one to buy?

ISRG vs TXN
Winner: TXN

Create New Comparison View All Competitors

Tradestie